Syros Pharmaceuticals, Inc.

Q2 2024 13F Holders

Symbol
SYRS
CUSIP
87184Q206
Type
Equity
Class
COM NEW
Num filings
76
Total reported value, excl. options
$105 M
Manager Report Date Value ($000) Shares Option Type